ICL Group Ltd. filed a Form 6-K incorporating its Notice of Annual Meeting and Proxy Statement for the meeting scheduled on September 17, 2026. The filing includes a CEO letter detailing 2025 financial results, with adjusted EBITDA of $1.5 billion and sales of $7.2 billion, alongside Q1 2026 performance showing adjusted EBITDA of $412 million and sales of $2.0 billion. ICL raised its full-year 2026 adjusted EBITDA guidance to a range of $1.5 billion to $1.7 billion. The company distributed $129 million in dividends during the first half of 2026, comprising two quarterly payments of $0.05 per share. Shareholders are voting on the re-election of nine directors and the reappointment of Somekh Chaikin as auditor. ICL Group Ltd. operates in the specialty chemicals industry, focusing on plant nutrition, specialty food solutions, and industrial products.
